Search Results 221-230 of 19151 for creatinine

1. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

   ... creatinine inmgdL);; Creatinine clearance for females = (140-age) (weight in kg) (0.85 )(72)(serum creatinine inmgdL). Negative pregnancy test done ≤ 7 days ...

2. Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG - Mayo Clinic

   Serum creatinine ≤2.0 x ULN. A serum creatinine >1 x ULN must also have creatinine clearance ≥50 mL/min. Hemoglobin ≥8.0 g/dL. Subjects receiving ...

3. First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) - Mayo Clinic

   provided that the total bilirubin is unchanged from the baseline value. d. Serum creatinine clearance by Cockcroft-Gault >30 mL/min - A patient with a ...

4. Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates - Mayo Clinic

   Creatinine within institutional limits of normal or creatinine clearance (CrCl) > 50 mL/min calculated using the Cockcroft-Gault equation. Women of ...

5. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Creatinine ≤ 1.5 x ULN or calculated or measured creatinine clearance ≥ 50 mL/min/1.73 m^2 (normalized to body surface area [BSA]) for patients with ...

6. Pharmacokinetic and Safety Study of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects with Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia - Mayo Clinic

   ... creatinine levels above or below the institutional normal value. If using creatinine clearance, actual body weight should be used for calculating creatinine ...

7. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

   Serum creatinine ≤ 1.5 x ULN, OR calculated creatinine clearance ≥ 30 mL/minute (modified Cockcroft and Gault formula); Urine protein to creatinine (UPC) ...

8. Ph. 1, Evaluation Of Safety, Tolerability, PK, Anti-tumor Activity Of STP707 IV In Subjects With Solid Tumors - Mayo Clinic

   o Serum creatinine ≤ 1.5 ULN or Creatinine Clearance ≥ 50 mL/minute 10. Acceptable hematologic status: - Hemoglobin ≥ 9 g/dL (a transfusion is allowed if ...

9. Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Serum Creatinine ≤ 1.5 x ULN or; Calculated Creatinine Clearance ≥ 70 ml/min; FEV-1 ≥ 1.2 liters/second or 50% predicted. Participating Mayo Clinic ...

10. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

    Creatinine Clearance (using the Cockcroft-Gault formula): < 60 mL/min; · Common Terminology Criteria for Adverse Events (CTCAE) version 4, grade 2 or above ...